2 options
FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Department of Health and Human Services. Office of Inspector General, author.
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration--Auditing.
- United States.
- United States. Food and Drug Administration.
- Medicare.
- Drugs--Risk assessment--United States--Evaluation.
- Drugs.
- Drugs--United States--Safety measures--Evaluation.
- Auditing.
- Physical Description:
- 1 online resource (34 pages) : illustrations
- Other Title:
- Food and Drug Administration lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety
- FDA lacks comprehensive data to determine whether REMS improve drug safety
- Place of Publication:
- [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2013.
- Notes:
- Title from title screen (viewed June 13, 2016).
- "February 2013."
- "OEI-04-11-00510."
- Includes bibliographical references.
- OCLC:
- 951671365
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.